DoubleTwist Licenses Prophecy, Prophecy ToolKit, Genomatrix to Organon | GenomeWeb

NEW YORK, Oct. 22 - DoubleTwist has licensed its Prophecy database, its Prophecy ToolKit, and its Genomatrix Promoter Resource database to pharmaceutical firm Organon, the bioinformatics company said on Monday.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.